MIAMI , Nov. 3, 2025 / PRNewswire/– Sitero, a technology-enabled Professional Research Organization(CRO), today revealed it has actually acquired the AI possessions and organization of studyOS- an unique eClinical AI modern technology supplier and maker of Ash-the AI Professional Test Agent.
The deal notes one more landmark in Sitero’s goal to deeply incorporate sophisticated modern technology with functional quality throughout the scientific development spectrum. The procurement enhances Sitero’s technique to integrate ingenious, regulation-ready AI services with best-in-class service delivery– creating a unified atmosphere where automation, analytics, and oversight merge to enhance rate, quality and conformity in international medical tests.
With this procurement, Sitero is introducing SiteroAI TM to become the industry’s initial truly AI-enabled CRO, offering AI-powered products that are already in use by customers and providing significant, quantifiable effectiveness gains across real-world research studies. With the combination of studyOS and Sitero’s Advisor eClinical system, SiteroAI TM anticipates to deliver 20– 30 % efficiency gains across the scientific advancement lifecycle for its customers in 2026, significantly improving time-to-market and reducing overall research costs, while improving information top quality.
Through the addition of studyOS’s Ash system, Sitero will expand the abilities of its Advisor eClinical suite and considerable medical solutions to offer sponsors a really smart AI operating framework that increases every phase of the trial lifecycle– from research study design and website activation through information testimonial, surveillance, and closeout. Ash’s natural-language interface permits groups to quiz, automate, and enhance test operations in genuine time, driving measurable effectiveness gains across Information Administration, Clinical Workflow, and Enroller Oversight tasks.
The combination of studyOS additionally reinforces Sitero’s growing profile of AI-driven devices aimed at encouraging sponsors and CRO companions to make faster, data-backed choices and decrease cycle times. The studyOS team, including crucial technological and AI engineering personnel, will sign up with Sitero to guarantee a smooth transition, connection of development, and sustained momentum in providing next-generation abilities that transform how research studies are performed around the world.
“We strongly rely on the possibility for purpose-built AI to be a transformative device for our industry,” stated Sankesh Abbhi, CEO of Sitero. “The studyOS system is among few options that have actually specifically built their AI intelligence from scratch to address essential challenges in our market. With this acquisition, I’m certain that our partners will not only obtain access to sector leading technology, however will likewise understand the cost-savings, performances and high quality improvements from our improved AI solutions.”
“Joining Sitero enables us to scale our AI vision across the complete scientific trial lifecycle,” claimed Ellis Butterfield, chief executive officer of studyOS. “Our team is enthusiastic about how AI can make it possible for novel operations that truly impact study timelines. By integrating our Ash platform with Sitero’s Advisor eClinical collection, we can supply a combined, AI-powered environment that drives measurable effectiveness throughout data monitoring, medical operations, and enroller oversight. Together, we’re not just advancing the speed of professional research, yet likewise redefining how innovation and intelligence converge to improve execution and decision-making for enrollers worldwide.”
As part of the procurement, Ellis Butterfield will be functioning as Sitero’s Chief Technology Policeman (CTO), reliable right away. Sitero prepares to incorporate Ash right into its proprietary Mentor eClinical collection, producing cross-system workflow capabilities that enhance effectiveness across multiple Coach offerings.
About Sitero
Sitero is a next-generation medical research partner sustaining life scientific researches and institutional research organizations in bringing therapies to market more secure and much faster. With a technology-forward strategy, Sitero improves research, drives compliance, and unlocks innovation. With global offices in the US, UK, Canada, Poland, Australia, Mexico, and India, Sitero incorporates professional talent with nimble execution throughout its scientific, regulative, and security solution lines.
Media Call
Logan Glynn
Senior Citizen Advertising Specialist
[emailย protected]
SOURCE Sitero, LLC
